Toxoplasmosis is a disease that is caused due to infection by the parasite Toxoplasma gondii, one of the world’s most common parasites.
Global Toxoplasmosis Diagnostic Testing Market: Snapshot
Toxoplasmosis is a disease that is caused due to infection by the parasite Toxoplasma gondii, one of the world’s most common parasites. Toxoplasmosis is caused because of consumption of improperly cooked pork, goat, mutton, or beef. It is also caused due to transfer of Toxoplasma gondii parasite via contaminated food, open wounds, or dust contaminated with cat feces.
Read Report Overview - https://www.transparencymarketresearch.com/toxoplasmosis-diagnostic-testing-market.html
Toxoplasma gondii parasite is found in bladder, kidneys, and intestines of infected persons. The parasite can also be transmitted from a pregnant woman to the developing fetus via the placenta. The seriousness of toxoplasmosis depends on the stage of pregnancy at which the infection is acquired. The transmission of infection to the developing fetus results in spontaneous abortion or premature birth.
Toxoplasmosis displays mild symptoms such as swelling in the lymph nodes and discomfort. Howbeit, toxoplasmosis infection in in HIV/AIDS cam result in serious life threatening condition. Toxoplasmosis can be severe or fatal in developing fetus, newborns, and individuals with weak immune systems.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14327
At present, immunoperoxidase stain and serology polymerase chain reaction are commonly used diagnostic tests for toxoplasmosis. Serology is employed to measure immunoglobulin G in infected persons. Toxoplasmosis testing involves a blood test to examine the availability of antibodies for T.godii. Toxoplasmosis diagnostic testing is generally offered at hospitals, public or private laboratories, and physician offices.
North America is currently the leading regional market for toxoplasmosis diagnostic testing. This is mainly because of rising prevalence of infectious diseases and high awareness among individuals about the availability of advanced diagnostic techniques. Europe ranks second among the key regions for toxoplasmosis diagnostic testing. However, Asia Pacific is anticipated to emerge as a significant market for toxoplasmosis diagnostic testing in the upcoming years owing to modernization of healthcare infrastructure in emerging economies.
Toxoplasmosis is an infectious disease caused by protozoan parasite Toxoplasma gondii, one of the world’s most dreaded parasite. There are 3 major genotypes of Toxoplasma gondii, namely (type 1, type 2, and type 3). These genotypes differ in their pathogenicity and prevalence among people around the world. Toxoplasmosis may be caused by transmission of T.gondii parasite through open wounds, consumption of contaminated raw meat, mutton, pork, beef, or by transfusion of blood, and organ transplant.
Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=14327
Healthy people usually exhibit flu like symptoms such as fever, fatigue, swollen lymph nodes, and headaches. People with a weak immune system augmented by conditions such as HIV/AIDS, are more likely to develop severe infections form the parasite. Toxoplasmosis can transmit transplacentally from mother to fetus if the mother becomes infected with toxoplasmosis during or just before pregnancy. The above mentioned condition may result into a miscarriage, a stillborn child, or with symptoms of toxoplasmosis. Diagnosis of Toxoplasmosis can be established by toxoplasmosis serologic profile (TSP) tests which include dye test (gold standard), indirect immune fluorescent test (IFAT), modified agglutination test (MAT), enzyme-linked immunosorbent assay (ELISA),immunoglobulin tests (IgG, IgM, and IgE antibodies tests).
Other test comes under TSP test includes amplification of specific nucleic acid sequences (i.e. PCR), histological diagnosis, and isolation of T.gondii parasite. In infant diagnosis can be performed by procedures such as amniocentesis, and ultrasound scan. Diagnosis can also be made by direct observation of the parasite in stained tissue sections, cerebrospinal fluids (CSF), and blood, but these procedures are less frequently used because of difficulty in obtaining samples.
Geographically toxoplasmosis diagnostic testing market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Currently North America dominates the toxoplasmosis diagnostic testing market, followed by Europe. In the U.S. and Europe, type 2 genotype is more prevalent among people than the other two species. Rising incidences of chronic diseases, along with major consumption of meat, pork, beef, and mutton, has resulted in increasing demand for effective testing methods for T.gondii by diagnostics laboratories in these regions.
Pre Book Toxoplasmosis Diagnostic Testing Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=14327<ype=S
Technological advancement would also boost the market demand for Toxoplasmosis diagnostic testing in the North America and Europe. By 2018, Asia Pacific region is expected to grow at fastest rate, owing to the large population base in the region, increasing incidences of chronic diseases, rising demand for technologically advanced diagnostic devices, region’s growing healthcare infrastructure, combined with government initiatives in providing better healthcare facilities.
Technological advancements in toxoplasmosis diagnostic testing such as touch down-multiplex PCR, increasing number of anti-infective drugs, and improving healthcare infrastructure around the world are some of the key drivers for the growth of toxoplasmosis diagnostic testing market. However, high cost of toxoplasmosis tests, and lack of awareness about the parasitic infection are some of the restraints in toxoplasmosis diagnostic testing market growth.
Improving safety and quality of toxoplasmosis diagnostic devices, improving healthc artte infrastructure focus on the emerging markets (China and India), and providing low cost devices, would act as a new opportunities for players in the global toxoplasmosis diagnostic testing market. On the basis of end – users, the toxoplasmosis diagnostic testing market has been segmented into hospitals, pathology laboratories, clinics, and diagnostic centers.
The major players in toxoplasmosis diagnostic testing market are Abbott Laboratories, Bio-Rad Laboratories, Inc. Affymetrix, Inc., and Beckman Coulter, Inc. Other players having presence in the toxoplasmosis diagnostic testing market includes Biotest Biomerica, Inc., Cepheid, Inc., and GenBio.
Browse More Trending Reports by Transparency Market Research:
The kinase inhibitors market is expected to expand at a modest CAGR of ~4% during the forecast period. However, innovations such as AI are transforming the market for kinase inhibitors. For instance, the U.S. biotechnology startup Insilico Medicine revealed its deep learning system that is capable of identifying potential treatments for fibrosis with the help of DDR1 (Discoidin Domain Receptor 1) kinase inhibitors.
Due to the limited availability of hearts for transplant, there is a growing demand for heart pump devices in order to improve survival rate. Hence, healthcare companies are increasing the availability of ventricular assist devices (VADs) for heart failure patients. For instance, in June 2019, medical devices company Abbott Laboratories revealed the HeartMate 3 left ventricular assist device (LVAD) nearly mimics the performance of a heart transplant. This is evident since VAD product segment of the heart pumps market is anticipated for exponential market during the forecast period. The global heart pumps market is expected to reach a value of ~US$ 4.3 Bn by the end of 2027.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/